ipharmaservicesMar 24EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenterNovartis' Fabhalta Receives Favorable CHMP Opinion for PNH Treatment Advancement UCB's Bimzelx (bimekizumab) garners favorable CHMP...
ipharmaservicesMar 21Lung Cancer | News | Updates | 2024 | iPharmaCenterKeytruda in combination with Lynparza failed to show PFS and OS improvement in patients with metastatic NSCLC Merck provided an update...